Pages that link to "Q37682563"
Jump to navigation
Jump to search
The following pages link to Review of medication adherence in children and adults with ADHD. (Q37682563):
Displaying 50 items.
- Medication for attention deficit-hyperactivity disorder and criminality (Q24619697) (← links)
- Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges (Q26822392) (← links)
- The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders (Q26851607) (← links)
- Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review (Q26859455) (← links)
- Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials (Q28081085) (← links)
- Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date (Q28250463) (← links)
- Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder (Q33779067) (← links)
- Effect of an Ecological Executive Skill Training Program for School-aged Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Clinical Trial (Q33864682) (← links)
- Data Mining in Healthcare and Biomedicine: A Survey of the Literature (Q33888044) (← links)
- Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence? (Q34274119) (← links)
- Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS) (Q34404578) (← links)
- Stimulant treatment of ADHD and cigarette smoking: a meta-analysis (Q34419671) (← links)
- Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: a fNIRS study (Q34431858) (← links)
- Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD. (Q34442413) (← links)
- Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial (Q34449469) (← links)
- Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial (Q34561459) (← links)
- Implementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder (Q34567343) (← links)
- The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan. (Q34681077) (← links)
- Management of newer medications for attention-deficit/hyperactivity disorder in commercial health plans. (Q34808555) (← links)
- An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence (Q35233612) (← links)
- Adherence with general healthcare among internal medicine outpatients with mental health treatment histories. (Q35570854) (← links)
- Changing patterns of alpha agonist medication use in children and adolescents 2009-2011 (Q35641630) (← links)
- Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder. (Q36029110) (← links)
- Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial (Q36086314) (← links)
- Cognitively and physically demanding exergaming to improve executive functions of children with attention deficit hyperactivity disorder: a randomised clinical trial (Q36244662) (← links)
- Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD. (Q36259685) (← links)
- Effectiveness of a focused, brief psychoeducation program for parents of ADHD children: improvement of medication adherence and symptoms (Q36306434) (← links)
- A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831). (Q36401245) (← links)
- Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies (Q36740926) (← links)
- A national epidemiological study investigating risk factors for police interrogation and false confession among juveniles and young persons (Q36761873) (← links)
- The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities (Q37111459) (← links)
- Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale. (Q37190637) (← links)
- Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia (Q37225350) (← links)
- Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder (Q37456591) (← links)
- Psychological contributors to noncompletion of an adolescent preoperative bariatric surgery program (Q37637400) (← links)
- Piloting a mobile health intervention to increase physical activity for adolescents with ADHD. (Q37731879) (← links)
- Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD (Q37803420) (← links)
- OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder (Q37827879) (← links)
- Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications (Q37893536) (← links)
- Challenges in the transition of care for adolescents with attention-deficit/hyperactivity disorder (Q38128174) (← links)
- Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults (Q38161921) (← links)
- Attention-deficit hyperactivity disorder (ADHD): an updated review of the essential facts (Q38203939) (← links)
- The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. (Q38221823) (← links)
- Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD). (Q38251282) (← links)
- Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study (Q38418781) (← links)
- Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009. (Q38430606) (← links)
- Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder. (Q38446579) (← links)
- A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder (Q38480352) (← links)
- Factors predicting treatment adherence in patients with adult attention-deficit/hyperactivity disorder: a preliminary study (Q38801256) (← links)
- Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications (Q38836941) (← links)